Lineage Reports First Quarter 2021 Financial Results and Highlights Significant Progress With All Three Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Lineage Reports First Quarter 2021 Financial Results and Highlights Significant Progress With All Three Clinical Programs

Lineage Cell Therapeutics (LCTX) Tops Q1 EPS by 2c

May 13, 2021 4:57 PM EDT

Lineage Cell Therapeutics (NYSE: LCTX) reported Q1 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $391 thousand versus the consensus estimate of $350 thousand.

For earnings history and earnings-related data on Lineage Cell Therapeutics (LCTX) click here.

... More